RGLS NASDAQ
Regulus Therapeutics Inc.
1W: -0.6%
1M: +3.2%
3M: +532.6%
1Y: +298.1%
3Y: +191.4%
5Y: -2.9%
$8.16
Last traded 2025-06-26 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$84M
+173.8% ▲
5Y CAGR: +14.9%
Total Liabilities
$8M
-18.7% ▼
5Y CAGR: -18.8%
Shareholders Equity
$76M
+260.6% ▲
5Y CAGR: +30.7%
Cash & Investments
$76M
+218.8% ▲
5Y CAGR: +17.3%
Total Debt
$274K
-88.5% ▼
5Y CAGR: -54.9%
Net Debt
-$38M
-78.9% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $31M | $60M | $24M | $24M | $39M |
| Short-Term Investments | $0 | $0 | $15M | $0 | $37M |
| Cash & ST Investments | $31M | $60M | $39M | $24M | $76M |
| Net Receivables | $503K | $0 | $0 | $0 | $0 |
| Inventory | $3M | $3M | $3M | $3M | $0 |
| Other Current Assets | $0 | $62K | $62K | $62K | $3M |
| Total Current Assets | $37M | $65M | $44M | $28M | $82M |
| Property, Plant & Equip. | $472K | $3M | $3M | $3M | $2M |
| Goodwill & Intangibles | $125K | $83K | $62K | $33K | $25K |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $277K | $291K | $0 | $0 | $0 |
| Total Non-Current Assets | $874K | $3M | $3M | $3M | $2M |
| Total Assets | $38M | $68M | $47M | $31M | $84M |
| — Liabilities — | |||||
| Accounts Payable | $535K | $285K | $175K | $204K | $947K |
| Short-Term Debt | $5M | $589K | $5M | $1M | $0 |
| Deferred Revenue | $3M | -$589K | $0 | $0 | $0 |
| Other Current Liabilities | -$451K | $706K | $3M | $5M | $5M |
| Total Current Liabilities | $12M | $5M | $12M | $9M | $7M |
| Long-Term Debt | $0 | $5M | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $1M | $0 | $0 | $0 |
| Total Non-Current Liabilities | $0 | $8M | $2M | $1M | $274K |
| Total Liabilities | $12M | $13M | $13M | $10M | $8M |
| — Equity — | |||||
| Common Stock | $67K | $146K | $17K | $20K | $66K |
| Retained Earnings | -$427M | -$455M | -$483M | -$513M | -$560M |
| Accumulated OCI | $0 | $0 | -$12K | $0 | $50K |
| Total Stockholders Equity | $26M | $55M | $33M | $21M | $76M |
| Total Liabilities & Equity | $38M | $68M | $47M | $31M | $84M |
| — Key Metrics — | |||||
| Total Debt | $5M | $7M | $6M | $2M | $274K |
| Net Debt | -$26M | -$53M | -$18M | -$21M | -$38M |
| Total Investments | $0 | $0 | $15M | $0 | $37M |